ABSTRACT: Veterinary drug residues in bulk tank milk are important to all sectors of the dairy chain because they are one of the major factors which determine the safety of the final product.
Introduction
The challenges to provide a food supply that is safe and nutritious are complex since all aspects of food production "from farm to fork" should be considered. Successful milk quality assurance programs start with farm bulk tank milk that is free of veterinary drug residues and has somatic cell counts (SCC) and bacterial counts that are both low resulting in better quality products with longer shelf lives (Ruegg and Tabone, 2000) .
Antibacterials, pyrethroids and macrocyclic lactones are the most widely used veterinary drugs in dairy cattle management for both disease therapy and the control of bacterial and parasitic infections (Toaldo et al., 2012) . Extensive and improper use of these active compounds can lead to the presence of their residues in milk, risks to human health, the development of microbial drug resistance, the spread of resistant pathogens, and a loss of industrial output and technological problems in dairy production (Ruegg and Tabone, 2000; Toaldo et al., 2012) . In this regard, an attempt should be made to identify and interpret the variation of milk quality parameters and the occurrence of veterinary drug residues from an integrated point of view because these variables reflect overall milk quality and management practices (Gonzalo et al., 2010) .
Identification of risk factors for discrimination between farms that are at higher risk for veterinary drug residues should allow for the cost-effective targeting of regulatory, educational and consultative resources. Although a number of previous studies have investigated the association between certain milk quality parameters and the occurrence of antimicrobial residues by screening methods (Ruegg and Talbone, 2000; Saville et al., 2000; Van Schaik et al., 2002; Shitandi and Kihumbu, 2004; Gonzalo et al., 2010) , more accurate chromatographic methods that are coupled with highly specific and sensible detection systems, such as tandem mass spectrometry, are required to identify and confirm the presence of these compounds (Molina et al., 2003; Samanidou and Nisyriou, 2008; Toaldo et al., 2012) . To our knowledge, this is the first study to attempt to identify associations between milk quality parameters and veterinary drug residues detected by confirmatory tests in bulk tank milk. We hypothesized that a number of quality parameters could be related to the presence of veterinary drug residues in raw milk. Thus, the present study attempted to identify the milk quality parameters that were associated with the occurrence of veterinary drug residues using multivariate principal component analysis (PCA).
Materials and Methods

Milk samples
Raw milk samples were collected from Aug 2009 to Feb 2010 from 45 dairy farms in the state of Minas Gerais, Brazil (Figure 1) . A total of 132 samples were collected from bulk milk tanks after milk homogenization. Given the extensive sampling that was required and the analysis cost, dairy herds were randomly selected based on the list of farms from the most important dairy plant in the region by considering their levels of daily milk production. Twenty-seven (60 %) of the dairy farms had production levels of ≤ 500 L d . Thus, the milk samples that were obtained were representative of the dairy farms belonging to the region of study. In the present study, a milk sample was assumed to be positive if any analytical residue was detected, regardless of the drug concentration. The milk samples were stored frozen at -18 °C until the quantitative analysis of veterinary drug residues was carried out.
Milk quality
Milk quality was assessed by the SCC, milk composition, total bacteria count (TBC) and titratable acidity level. The SCC and milk composition (fat, total protein, lactose, nonfat solid and total solid contents) was analysed using automated equipment (CombSystem 2300 ® , Bentley Instruments, Chaska, USA) from milk samples that were collected in 40 mL vials containing microtablets of bronopol (2-bromo-2-nitropane-1,3-diol). TBCs were determined with a Bactocount ® unit (Bentley Instruments, Chaska, USA) from milk samples that were collected with azidiol (3 μL mL −1 ). Samples for titratable acidity were evaluated using the Dornic method (Tamine and Robinson, 1999) . They were collected without any preserving agent and stored at 4 °C until analysis.
Chemicals and standard solutions Pesticides
The analytical standards γ-cyhalothrin (γCYH), λ-cyhalothrin (λCYH), cyfluthrin (CYF), cypermethrin (CYP), deltamethrin (DEL), fenvalerate (FEV) and permethrin (PER), which all possessed levels of 95 % certified purity, were obtained from Sigma-Aldrich (St. Louis, MO, USA). For the pyrethroids, standard stock solutions of 1 mg mL −1 were prepared individually in acetonitrile (ACN) and stored in a refrigerator at 8 °C. Working standard solutions containing all of the pyrethroids were diluted with ACN to give calibration solutions ranging from 5.0 ng mL −1 to 80.0 ng mL −1
. All of the standard solutions were stored at -20 °C.
Macrocyclic lactones and antibacterials
The following analytical standards: penicillin G (PNG), penicillin V (PNV), ceftiofur (CFT), cloxacillin (CLX), dicloxacillin (DCX), oxacillin (OXA), chlortetracycline (CTC), doxycycline (DOX), tetracycline (TC), oxytetracycline (OTC), oxolinic acid (OXO), nalidixic acid (NALIDIX), flumequine (FLU), difloxacin (DIFLO), ciprofloxacin (CIPRO), enrofloxacin (ENRO), norfloxacin (NOR), sarafloxacin (SARA), trimethoprim (TMP), sulfadimethoxine (SDMX), sulfaquinoxaline (SQX), sulfadiazine (SDZ), sulfathiazole (STZ), sulfapyridine (SPY), sulfamethoxazole (SMA), sulfamethazine (SMZ), sulfachloropyridazine (SCP), sulfisoxazole (SFX), sulfadoxine (SDX), sulfamerazine (SMR), ivermectin (IVR), eprinomectin (EPR), emamectin (EMA), doramectin (DOR), abamectin (ABA) and moxidectin (MOX) were purchased from Sigma Aldrich (St. Louis, MO, USA) as Vetranal TM analytical-grade standards (> 95 % certified purity).
For the β-lactams, stock standard solutions were prepared by dissolving all of the compounds in polypropylene glycol 3000 in acetate buffer (pH = 4.5) at concentrations ranging from 0.5 to 3.75 mg mL −1 . For the tetracyclines, sulfonamides and fluoroquinolones, a stock standard solution of each compound was prepared by dissolving 10 mg of the analytical standard in 10 mL of the appropriate solvent (acetonitrile for the tetracyclines and sulfonamides, methanol with a couple of drops (~2) of 1 M NaOH for the fluoroquinolones and methanol for the TMP). Aliquots of each stock solution were diluted to obtain final concentrations of 10 μg mL solutions were prepared by combining aliquots of each stock solution in ACN to obtain final concentrations of 1 μg mL −1 for ABA, IVR and MOX, 1.5 μg mL −1 for DOR and 2.0 μg mL −1 for EPR in ACN. EMA was used as an internal standard, and its working solution was prepared at 1.0 μg mL −1 in ACN. All of the reagents were of analytical grade unless otherwise indicated. Acetic acid, trichloroacetic acid, ACN (MeCN, MS-grade), ethanol and methanol (MeOH, MS-grade) were purchased from Merck (Darmstadt, Germany). Formic acid and triethylamine were supplied by J.T. Baker (Phillipsburg, NJ, USA). Deionized ultra-pure water (< 18.2 MΩ cm resistivity) was obtained from the Milli-Q SP Water System (Millipore, Bedford, MA, US). Disodium EDTA (Na 2 EDTA) was obtained from Sigma. Ammonium acetate (analytical grade) was obtained from Mallinckrodt-Baker (Phillipsburg, NJ, USA).
Equipment and chromatographic conditions
Gas chromatograph with electron capture detector (GC-ECD) for pyrethroids
The analytical system used for this study was a Trace GC Ultra gas chromatograph (Thermo Fisher Scientific, Milan, Italy) equipped with a splitless injection system, AI 3000 autosampler and . The conditions for pyrethroid separation using the OV-35 column were similar to those used for the OV-5 column. The injector and detector were programmed at 240 °C and 340 °C, respectively. Nitrogen at 1.0 mL min −1 was used as the carrier gas. One microliter of each sample was injected in splitless mode. Identification of the peaks was based on comparisons of the retention times of compounds in the standard solutions.
Liquid chromatography coupled with mass spectrometry in tandem mode (LC-MS/MS) multi-residue screening
Prior to the quantitative analysis, an LC-MS/ MS multi-residue screening method was applied to the qualitative analysis of fluoroquinolones, tetracyclines, sulfonamides and trimethoprim in milk. The LC-MS/MS screening analysis was performed using a Waters Alliance 2795 system (Milford, USA) coupled to a Micromass Quattro Micro triple quadrupole mass spectrometer (Waters, Milford, USA) with an electrospray source. The multi-residue separation was performed in a Waters Symmetry C18 LC column (75 mm × 4.6 mm, 3.5 μm). A Phenomenex C18 column (4.0 mm × 3.0 mm) was used as the guard column. A gradient elution program with solvent A (aqueous solution of 0.1 % formic acid) and solvent B (ACN with 0.1 % formic acid) was used. The chromatographic conditions and mass spectrometry parameters were chosen according to Bittencourt et al. (2011) . The detection was performed in multiple reaction monitoring mode, and the 2 m/z transitions were monitored for each analyte. The m/z transitions that were associated with the retention times of the analytes provided confirmatory data, fulfilling the requirements for a confirmatory analysis. For positive results, quantitative methods were applied to determine the analyte concentrations.
LC-MS/MS (macrocyclic lactones and antibacterials)
The LC system used in this study was an Agilent 1100 series LC (Santa Clara, CA, USA) with a quaternary pump, a vacuum degasser and an autosampler, which was coupled to an API 5000 triple quadrupole mass spectrometer (Applied Biosystems, Foster City, CA, USA) with an electrospray ionization interface. The chromatographic separation of the β-lactams was performed using a Phenomenex Synergy® C18 analytical column (150 × 3.0 mm, 4.0 μm) that was preceded by a security guard C18 column (4.0 × 3.0 mm, 5 μm) (Phenomenex). A binary mobile phase was used with a flow of 500 μL min −1 for a total run time of 12 min. Mobile phase component A was an aqueous solution of 0.1 % formic acid, and component B was ACN with 0.1 % formic acid. The detailed chromatographic and mass spectrometry conditions are provided in Jank et al. (2011) .
For the tetracyclines, separation was performed on an Xterra C18 column (2.1 mm × 100 mm, 1.7 μm) preceded by a security guard C18 column (4.0 × 3.0 mm, 5 μm) (Phenomenex). The mobile phase was applied in gradient mode, using water with 0.05 % formic acid (solvent A) and ACN with 0.05 % formic acid (solvent B).
Separation of the fluoroquinolones was performed on a Waters Symmetry C18 column (75 mm × 4.6 mm, 3.5 μm) with a Phenomenex C18 (4.0 mm × 3.0 mm) guard column via a gradient elution process, using an aqueous solution of 0.1 % formic acid as solvent A and ACN with 0.1 % formic acid as solvent B. For the sulfonamides and trimethoprim, separation was performed on a Zorbax ® XDB C18 column (150 × 4.6 mm, 5 μm) (Agilent). The mobile phase was composed of 10 mM ammonium acetate that was acidified with 0.01 % acetic acid (solvent A) and methanol (solvent B) using a gradient system. The detailed parameters are described in Hoff et al. (2009) .
Separation of the macrocyclic lactones was performed on a Luna C18 column (150 mm × 2.1 mm, 5 μm) that was preceded by a guard column (4 mm × 3 mm, 5 μm) consisting of the same packing material (Phenomenex, Torrance, CA, USA). All of the analytes were eluted after 4 min using an isocratic mobile phase consisting of 50 mM ammonium acetate buffer (pH 5):ACN 
Sample preparation procedure
Pyrethroids
Milk samples (5.0 mL) were extracted with 10 mL of ACN in 50 mL polypropylene tubes, shaken for 20 min and then incubated in a freezer at -20 °C for approximately 12 h. After this period, the organic phase, which contained an organic solvent with the extracted compounds, remained in liquid form, whereas the aqueous phase and lipidic fraction of the milk froze. The supernatants were passed through previously cooled glass wool containing anhydrous sodium sulfate (2.0 g). The extracts were concentrated until dry in a water bath (38-40 °C) under gentle nitrogen flow. The residues were dissolved in 1.0 mL of ACN and analyzed by GC-ECD.
Qualitative determination of fluoroquinolones, tetracyclines, sulfonamides and trimethoprim
Aliquots (500 μL) of the raw milk samples were extracted in microcentrifuge tubes (1.5 mL) by the addition of 20 μL of 20 mM EDTA and 200 μL of acidified ethanol (3 % acetic acid). The samples were vortexed for approximately 15 s and then centrifuged at 10,000 g at 5 °C. Aliquots of the supernatants were diluted with water:ACN (1:1, v/v, both with 0.1 % formic acid) in high-performance liquid chromatography (HPLC) vials and subjected to multi-residue analyses. Ten microliter volumes were injected into the LC-MS/MS system.
Antibacterials
β-lactams were determined as described in Jank et al. (2011) . The extraction procedure consisted of the sequential addition of 1.0 mL of ACN to 2.0 mL of milk four times, with vortexing between each addition. The sample was then mixed in a head-over-head shaker for 15 min; 1.0 g of sodium chloride was added, and the sample was mixed in the shaker for an additional 15 min. The samples were centrifuged for 5 min at 3,000 g at 5 °C. Aliquots of the supernatant were transferred to HPLC vials, and a 10 μL volume was injected into the chromatograph.
For the quantitative analysis of tetracyclines, 500 μL of milk was placed in a microcentrifuge tube (2.0 mL), and 5 μL of 100 mM EDTA was then added. After mixing for 15 s, 200 μL of acidified ethanol (3 % acetic acid) was added. The samples were then mixed (15 s) and centrifuged for 10 min at 12,000 rpm at 5 °C. An aliquot of the supernatant (350 μL) was diluted with water (650 μL) in an HPLC vial and subjected to LC-MS/ MS analysis.
The quantitative analysis of fluoroquinolones was performed using the same procedure as described above in "Qualitative analysis of fluoroquinolones, tetracyclines, sulfonamides and trimethoprim"; a matrixmatched calibration curve and a specific mass spectrometry method were used for the quantification of fluoroquinolone.
To determine the presence of sulfonamides and trimethoprim, 500 μL of milk was vortexed for 15 s to homogenize, and the analyte extraction was performed with 200 μL of acidified ethanol (3 % acetic acid). The extract was mixed for 15 s and centrifuged for 10 min at 12,000 rpm at 5 °C. An aliquot of the supernatant (350 μL) was diluted with water (650 μL) in an HPLC vial, and 10 μL was injected into the chromatograph for LC-MS/MS analysis.
Macrocyclic lactones
Extraction of the samples was performed as described in Rübensam et al. (2011) . For the procedure, 5.0 mL of milk was extracted with four aliquots of 2.5 mL of ACN using liquid-liquid extraction with low temperature purification. To this mixture, 2 g of sodium chloride was added, and the sample was shaken until the salt dissolved. Then, the mixture was centrifuged at 5 °C for 10 min at 2,200 g. The top phase was transferred to a 15 mL polypropylene centrifuge tube and incubated in a freezer for 12 h at -20 °C. The remaining liquid phase was then transferred to a new 50 mL centrifuge tube and evaporated in a water bath (50-55 °C) under a gentle nitrogen flow until completely dry. Finally, the dry extract was reconstituted in 1 mL of ACN for further LC-MS/ MS analysis.
Quality assurance and method performance
All of the samples were subjected to all of the previously described methods. First, the samples were analyzed by a LC-MS/MS screening method for antibacterial residues. For each positive result, a LC-MS/MS quantitative and confirmatory analysis was performed. All of the methods have been fully validated and are currently in routine use in the laboratory network of the Ministry of Agriculture, Livestock and Food Supply of Brazil (MAPA) for the NRCCP (Lins et al., 2012) . The results were corrected for recovery. All of the methods applied met the internal criteria for residue analysis.
Statistical analysis
First, the distribution of all of the variables was examined with normal probability plots using the Kolmogorov and Smirnov tests. To compare the differences between the milk samples with negative and positive results for antibacterial, macrocyclic lactone and pyrethroid residues, an unpaired t-test was used for the data with normal distributions, and the Mann-Whitney Rank test was used for the nonparametric data. All of the SCCs and TBCs were log 10 -transformed because the distributions were not normal. The significance was set to p ≤ 0.05 unless otherwise indicated. The statistical analyses were performed using the GraphPad Prism 5.0 software ® (GraphPad Software, Inc., San Diego, CA, USA). Furthermore, multidimensional PCA was performed using the STATA statistical software version 12 (Stata Corp., College Station, Texas, USA). To test the associations among all of the variables that were surveyed together, a PCA was performed to assess inferences regarding the pos-sible biological meanings underlying the associations between the variables without the pre-establishment of cause/effect. Thus, this statistical technique allows us to graphically visualize the variables in the same dimensional plane and establish relationships between them. The minimum percentage of inertia of the system for the multidimensional PCA was 65 % in relation to the percentage of variance that was explained by the first three axes (components).
Results
In this study, at least one veterinary drug residue was identified in 40 samples (30 %) by confirmatory tests (above the detection limit), whereas 16 samples (12 %) showed the presence of at least two residues. The antibacterial residues in bulk milk tank detected by confirmatory tests were PNV (n = 1. 1 %), CFT (n = 7. 5 %), OXA (n = 2. 2 %), DCX (n = 2. 2 %), OTC (n = 3. 2 %), CIPRO (n = 3. 2 %) and ENRO (n = 3. 2 %). The macrocyclic lactones detected in raw milk were ABA (n = 7. 5 %), DOR (n = 3. 2 %) and IVR (n = 10. 8 %). The pyrethroid residues detected by GC-ECD in bulk milk tank were CYP (n = 12. 9 %) and DEL (n = 2. 2 %).
The bulk tank milk samples that tested positive for antibacterial residues by confirmatory methods had higher lactose (p < 0.0001), total solid (p = 0.004), nonfat solid (p = 0.001) and fat (p = 0.05) concentrations. Indeed, the milk samples with antibacterial residues showed a tendency toward lower titratable acidity (p = 0.06) and lower protein (p = 0.06) concentration (Table  1) . No difference in milk quality parlameters was observed in the samples with macrocyclic lactone residues, although they tended to have lower titratable acidity (p = 0.07) ( Table 1) . No difference was observed in the bulk tank milk samples with pyrethroid residues compared to the samples lacking pyrethroid residues (Table 1) .
The PCA revealed that the lactose and nonfat solid concentrations were associated with the presence of antibacterial residues in the bulk tank milk (Figure 2A ; Table 2). The macrocyclic lactone residues in the bulk tank milk were associated with fat and total solids concentrations, TBC and SCC ( Figure 2B ; Table 3 ). The detection of pyrethroid residues in bulk tank milk was inversely associated with titratable acidity levels and lactose and nonfat solid concentrations ( Figure 2C ; Table 4 ).
Discussion
This study identified 12 out of the 42 veterinary drug residues that were under investigation. These data highlight the crucial importance of the role of the dairy industry and government regulatory agencies as monitors of veterinary drug residues in milk combined with incentive, education and training programs in an attempt to reduce the prevalence of excessive veterinary drug residue levels in raw milk.
In this study, higher lactose, total solid, nonfat solid and fat concentrations and the tendency toward higher protein concentrations in the milk samples with antibacterial residues were found. The PCA analysis also confirmed an association between lactose and nonfat solid content with the presence of antibacterial residue in bulk tank milk. One factor that might explain these results could be the management practices and the genetic selection of dairy cattle. The emphasis on maximizing milk production and quality by genetic selection and management practices can lead to increased metabolic demands resulting in oxidative stress. Oxidative stress, especially in high producing animals, is a significant underlying factor in the dysfunctional host immune response, which can increase the susceptibility of dairy cattle to a variety of health disorders (Sordillo and Aitken, 2009 ) and, as a result, contribute to the use of antimicrobials in dairy farms. In fact, the breeding of cattle for enhanced milk production has been reported to negatively affect health and fertility traits (Veerkamp et al., 2005; Ouweltjes et al., 2007) .
In agreement with our results, Shitandi and Kihumbu (2004) in Kenya reported that the California Mastitis Test (239 milk samples from 45 smallholder dairy herds) was not a risk factor for violative antimicrobial residues in milk. On the other hand, some previous studies described that higher bulk milk SCC levels are associated with antibacterial residues violations using screening methods (Ruegg and Tabone, 2000; Saville et al., 2000) . The screen test displayed 3 components. Acidity = titratable acidity; SCC = somatic cell count; TBC = total bacteria count. The screen test displayed 3 components. Acidity = titratable acidity; SCC = somatic cell count; TBC = total bacteria count.
Figure 2 − Plot of the principal multidimensional components analysis (PCA) of antimicrobial (A), macrocyclic lactone (B) and pyrethroid (C) residues by confirmatory methods and their correlations with milk quality parameters (titratable acidity (acidity), protein, fat, lactose, total solid (TS) and nonfat solid (NS) concentrations, somatic cell counts (SCC) and total bacteria counts (TBC)) for components 1 (x axis) and 2 (y axis) of the PCA. The variables in the same quadrant were closely associated, and those in opposite quadrants had opposite effects (components 1 and 2). The variables in other quadrants were regarded as independent variables.
Therefore, the lack of recommendation for the treatment of subclinical mastitis during lactation in dairy cattle in Brazil (Reis et al., 2003; Zafalon et al., 2007) may also explain why the SCC was not associated with antibacterial residues in bulk tank milk in this study. Furthermore, it is possible that the hierarchy of risk factors differs depending on the region and the herds that are under investiga- The screen test displayed 3 components. Acidity = titratable acidity; SCC = somatic cell count; TBC = total bacteria count.
tion. For instance, Van Schaik et al. (2002) described that larger farms in the New York State -USA had lower SCC and bacteria counts, but more antibiotic violations. The PCA showed that the fat and total solid concentrations, the SCC and the TBC were associated with macrocyclic lactone residues in bulk tank milk. Congruently, it has been reported that cows that have been treated with anthelmintics have greater milk fat yields than untreated controls (Gross et al., 1999) . Further, several infections with non-mastitis pathogens appear to be associated with udder health (Barkema et al., 2009) . For instance, the detrimental effects of gastrointestinal nematodes on the immune responses of cows (Gasbarre, 1997) may affect udder health, and consequently increase the SCC (an indicator of mammary gland health) and the TBC, as these milk quality parameters appear to be associated (Pantoja et al., 2009) .
The PCA for pyrethroid residues in bulk tank milk revealed an inverse association with lactose and nonfat solid concentrations as well as titratable acidity levels. The months during which the dairy cows experienced increased infestation by insects and ticks, such as horn flies (Haematobia irritans) and Rhipicephalus (Boophilus) microplus, coincided with the time period that the cows primarily remained on the pasture (Estrada-Peña et al., 2006) . Because treatment with pyrethroids is mainly based on the subjective observation of infestation levels, treatment of these animals is typically increased (Da Rocha et al., 2012) in months when cows remained on the pasture. A positive relationship between milk lactose and energy balance has been proposed, suggesting that milk lactose concentrations are affected by energy balance (Schei et al., 2005; Beerda et al., 2007; Ouweltjes et al., 2007) . Thus, pasture cows, which use energy to walk to and from the grazing padlocks in addition to expending during grazing, most likely expend more energy than confinement-fed cows. This increased energy expenditure could impact their energy balances and, consequently, milk lactose concentrations (Ouweltjes et al., 2007) . Collectively, the data regarding the positive relationship between milk lactose and energy balance may explain why lactose concentrations were inversely related to pyrethroid residues (Schei et al., 2005; Beerda et al., 2007; Ouweltjes et al., 2007) .
Data analyses indicated that the veterinary drug residues that were detected using the laborious and expensive confirmatory tests were associated with some milk quality parameters that are easy, fast and cheap parameters for dairy plants. Thus, a number of milk quality parameters can be used in a large scale to target farms that are at higher risk for veterinary drug residues for testing programs in combination with incentives, education and training programs to improve mammary health, milk hygiene and safety.
